September 18, 2025

Semaglutide Reduced HbA1c, Weight in Schizophrenia

First trial shows semaglutide maintains psychiatric stability while improving metabolic outcomes in patients with schizophrenia.

Conexiant

September 17, 2025

Dating a Dinosaur Egg, Directly

A methodological milestone in palaeontology could eliminate long-standing uncertainties in fossil dating 

The Analytical Scientist

September 16, 2025

Tirzepatide More Cost-Effective Than Semaglutide in Knee Osteoarthritis

Roux-en-Y gastric bypass offers highest value in obesity with knee osteoarthritis.

Conexiant

September 16, 2025

Oral Bacteria Found Deep in Heart Plaques

Viridans streptococci DNA detected in over 40 percent of atherosclerotic samples, suggesting a role in destabilization

The Pathologist

September 16, 2025

Mapping Missense Mutations with Proteogenomics

Using SILAC mass spectrometry and mutation databases, researchers uncover how missense variants reshape protein abundance in prostate cancer 

The Analytical Scientist

September 15, 2025

GLP-1 May Aid Fertility, Raise Risks

Pregnancies occur within six months of GLP-1 use as contraception at initiation stays low.

Conexiant

September 15, 2025

1 in 5 US Med Students Food Insecure, Study

Loans, debt, and dependents drove food insecurity among US medical students.

Conexiant

September 15, 2025

Dana-Farber Research News 09.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 16 - August 31.

Dana-Farber

September 15, 2025

C-Peptide at 16 Weeks Predicted Gestational Diabetes

C-peptide measured at 16 weeks during an OGTT distinguishes patients who later develop gestational diabetes.

Conexiant